Panel Discussion: Biotech’s New Approaches to Solid Tumors

Apella by Alexandria April 16, 2020 12:15 pm - 1:00 pm

Bookmark and Share

Peter Dudek, PhD
Mitchell H. Finer, PhD
Jenna Foger

Early-stage biotech companies present new approaches to attacking solid tumors. These companies are driving advances in cell and gene therapy for solid tumors including glioblastoma and pancreatic cancer but there are significant challenges in raising capital – who will take the lead to advance early biotech programs in solid tumors so other investors will follow?